Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mangoceuticals, Inc. ( (MGRX) ) just unveiled an update.
On September 9, 2025, Mangoceuticals, Inc. granted shares and options to key executives and board members as part of their 2022 Equity Plan. CEO Jacob D. Cohen received 500,000 shares and options to purchase 2,000,000 shares, while other executives and board members received 100,000 shares each. The options have a ten-year term and specific vesting conditions, reflecting the company’s strategy to incentivize leadership and align their interests with company performance.
More about Mangoceuticals, Inc.
Average Trading Volume: 158,356
Technical Sentiment Signal: Hold
Current Market Cap: $22.44M
For detailed information about MGRX stock, go to TipRanks’ Stock Analysis page.